why choose us

First received: May 24, 2023

Clinical Trial: Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: NSCLC

Study Type: INTERVENTIONAL


Official Title: Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects

Brief Summary: This study is divided into Part I and Part II.Part I is the food effect study.A total of 20 healthy subjects, regardless of gender, will be enrolled in a randomized, open-label, crossover design.Part II is the drug-drug interaction study, an open-label and sequential design.32 healthy subjects are planned to be enrolled and divided into group A and group B. Group A is to evaluate the influence of itraconazole as CYP3A4 strong inhibitory on HLX208.Group B was to evaluate the effect of rifampicin as a strong inducer…

Read more